GENE ONLINE|News &
Opinion
Blog

2026-06-04|

Glucose Health, Inc. Appoints Former Celsius CEO Gerry David to Strategic Advisory Board

by GOAI
Share To

Glucose Health, Inc. appointed Gerry David as the chairman of its Strategic Advisory Board of Directors on Thursday, June 4, 2026. In this new role, David will oversee the company’s strategic initiatives and provide guidance to the board regarding corporate development.

David brings experience from his previous tenure as the president and chief executive officer of Celsius Holdings, Inc., where he led the company’s growth and market expansion. Glucose Health, Inc. intends to utilize his background in the consumer goods and health sectors to support its ongoing business operations. The company confirmed the appointment as part of its efforts to strengthen its advisory leadership team.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 4, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
2026-06-11
nVent Electric Appoints New Chief Strategy and Revenue Officers
2026-06-10
Snail Games Announces Bellwright Console Launch and New ARK Content at IGN Live 2026
2026-06-10
BJJLink Launches AI-Powered Platform for Martial Arts Gym Member Acquisition
2026-06-10
Trump Media and TAE Technologies Provide Merger Status Update on June 10, 2026
2026-06-10
OZOP Energy Solutions Partners with Tenace Consulting for Southern California Distribution
2026-06-10
Agassi Sports Entertainment Signs Darren Cahill to Lead Global Coaching and Technology Initiatives
2026-06-10
Scroll to Top